Get the Stockscreener App
2.80
2.19%
0.06
After Hours:
2.86
0.06
+2.14%
Accendra Health Inc stock is traded at $2.80, with a volume of 1.27M.
It is up +2.19% in the last 24 hours and up +0.00% over the past month.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
See More
Previous Close:
$2.74
Open:
$2.74
24h Volume:
1.27M
Relative Volume:
0.67
Market Cap:
$216.57M
Revenue:
$10.42B
Net Income/Loss:
$-38.77M
P/E Ratio:
-5.4902
EPS:
-0.51
Net Cash Flow:
$323.54M
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
-16.42%
1Y Performance:
-65.77%
1-Day Range:
$2.69
$2.82
1-Week Range:
$2.69
$2.82
52-Week Range:
$2.38
$9.55
Accendra Health Inc Stock (OMI) Company Profile
Name
Accendra Health Inc
Sector
Industry
Phone
(804) 723-7000
Address
10900 NUCKOLS ROAD, GLEN ALLEN, VA
Compare OMI vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMI
Accendra Health Inc
|
2.80 | 216.57M | 10.42B | -38.77M | 323.54M | -0.51 |
MCK
Mckesson Corp
|
801.01 | 98.95B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
305.90 | 59.07B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
197.00 | 46.15B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
74.37 | 8.26B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.20 | 1.83B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (OMI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Downgrade | UBS | Buy → Neutral |
| Jul-19-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-12-22 | Downgrade | BofA Securities | Buy → Underperform |
| Oct-12-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-26-22 | Resumed | Citigroup | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-30-22 | Resumed | JP Morgan | Underweight |
| Dec-17-20 | Upgrade | UBS | Neutral → Buy |
| Sep-25-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-05-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Jan-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-10-19 | Reiterated | BofA/Merrill | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-01-18 | Reiterated | Barclays | Underweight |
| Oct-31-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-08-18 | Initiated | Barclays | Underweight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Dec-19-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-01-17 | Upgrade | Robert W. Baird | Underperform → Neutral |
| Nov-07-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Apr-21-16 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-16-16 | Initiated | Credit Suisse | Underperform |
| Dec-07-15 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Accendra Health Inc Stock (OMI) Latest News
Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call - Weekly Voice
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
MSN Money - MSN
Accendra Health (ACH) price target decreased by 69.55% to 3.77 - MSN
Owens & Minor to rebrand as Accendra Health, change ticker to "ACH" - MSN
Is the Options Market Predicting a Spike in Accendra Health Stock? - MSN
ACH Financials: Income Statement, Balance Sheet & Cash Flow | Accendra Health Inc - Stock Titan
ACH Stock Price, News & Analysis | Accendra Health - Stock Titan
Lobbying Update: $280,000 of ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR INC.") lobbying was just disclosed - Quiver Quantitative
ACH Options Volatility — NYSE:ACH - TradingView
Is Accendra (ACH) Stock Underperforming | Price at $2.65, Up 0.95%MACD Signals - Newser
OMI.N Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OMI.N News & Events - Intellectia AI
ACH Stock Analysis: Accendra Health Inc. healthcare stock 6.05 percent rise at 2.63 review - Newser
OMI.N Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
ACH SEC FilingsAccendra Health Inc 10-K, 10-Q, 8-K Forms - stocktitan.net
Accendra Health (ACH) details 2025 results, home-care focus and pay votes in 2026 proxy - Stock Titan
[ARS] ACCENDRA HEALTH INC/VA/ SEC Filing - Stock Titan
Accendra Health, Inc. (ACH) stock price, news, quote and history - Yahoo Finance Australia
Kevin M. Webb reports 5.61% stake in Accendra Health (NASDAQ: ACH) - Stock Titan
Owens & Minor Appoints Colin Bain as Chief Products Officer, Effective March 30, 2026 - MarketScreener
Vanguard disaggregates holdings; Accendra Health (ACH) listed as 0 shares in amendment - Stock Titan
Accendra Health (ACH) CEO surrenders shares to cover RSU tax obligations - Stock Titan
Accendra Health (ACH) CFO surrenders 11,286 shares for tax withholding - Stock Titan
Accendra Health (ACH) COO surrenders shares for tax withholding, retains stake - stocktitan.net
Accendra Health (ACH) EVP uses 9,347 shares to cover tax withholding - Stock Titan
OMI SEC FilingsOwens & Minor 10-K, 10-Q, 8-K Forms - Stock Titan
Tranche Update on Accendra Health, Inc.'s Equity Buyback Plan announced on February 28, 2025. - marketscreener.com
Fitch Maintains Accendra Health's Rating Watches; Withdraws Ratings - MarketScreener
Is the Options Market Signaling a Surge in Accendra Health Shares? - Bitget
OMI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Accendra Health CFO granted 85,067 restricted shares | ACH Insider Trading - Stock Titan
ACH Technical Analysis & Stock Price Forecast - Intellectia AI
Owens & Minor, Inc. (OMI) Stock Analysis: Is The 94% Potential Upside Worth The Risk? - directorstalkinterviews.com
Owens & Minor, Inc. (NYSE:OMI) Q4 2025 Earnings Call Transcript - Insider Monkey
Accendra Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:ACH) 2026-02-25 - Seeking Alpha
Accendra Health (ACH) Price Target Decreased by 12.16% to 3.32 - Nasdaq
Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care - Insider Monkey
UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com Canada
UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com South Africa
Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks
Accendra Health Inc Stock (OMI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):